首页> 外文期刊>American journal of clinical pathology. >Immunohistochemical Assessment of the Diagnostic Utility of PD-L1 (Clone SP142) for Methotrexate-Associated Lymphoproliferative Disorders With an Emphasis of Neoplastic PD-L1 (Clone SP142)-Positive Classic Hodgkin Lymphoma Type
【24h】

Immunohistochemical Assessment of the Diagnostic Utility of PD-L1 (Clone SP142) for Methotrexate-Associated Lymphoproliferative Disorders With an Emphasis of Neoplastic PD-L1 (Clone SP142)-Positive Classic Hodgkin Lymphoma Type

机译:PD-L1(克隆SP142)对甲氨蝶呤相关的淋巴抑制性疾病的免疫组化评估,其强调肿瘤PD-L1(克隆SP142) - 阳性经典霍奇金淋巴瘤型

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: We describe results of programmed death ligand 1 (PD-L1) immunohistochemical assessment in methotrexate (MTX)-associated lymphoproliferative disorders (LPDs) and highlight the characteristics of classic Hodgkin lymphoma (CHL) type MTX-LPD.
机译:目的:我们描述了甲氨蝶呤(MTX) - 分配的淋巴抑制性疾病(LPD)中编程死亡配体1(PD-L1)免疫组化评估的结果,并突出了经典霍奇金淋巴瘤(CHL)型MTX-LPD的特征。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号